Short Interest in Cellebrite DI Ltd. (NASDAQ:CLBT) Expands By 13.6%

Cellebrite DI Ltd. (NASDAQ:CLBT - Get Free Report) saw a significant increase in short interest during the month of December. As of December 31st, there was short interest totalling 1,170,000 shares, an increase of 13.6% from the December 15th total of 1,030,000 shares. Approximately 1.4% of the company's stock are short sold. Based on an average daily trading volume, of 1,310,000 shares, the days-to-cover ratio is presently 0.9 days.

Analysts Set New Price Targets

A number of analysts recently commented on the stock. Craig Hallum lifted their target price on shares of Cellebrite DI from $23.00 to $24.00 and gave the stock a "buy" rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. boosted their price objective on shares of Cellebrite DI from $22.00 to $24.00 and gave the company an "overweight" rating in a report on Monday, December 16th. TD Cowen raised their target price on Cellebrite DI from $20.00 to $23.00 and gave the stock a "buy" rating in a research note on Monday, September 23rd. Finally, Needham & Company LLC lifted their price target on Cellebrite DI from $17.00 to $21.00 and gave the stock a "buy" rating in a research report on Thursday, November 7th. Eight equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of "Buy" and a consensus price target of $20.57.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in CLBT. Quarry LP acquired a new stake in shares of Cellebrite DI during the 3rd quarter valued at about $27,000. Point72 Asia Singapore Pte. Ltd. grew its holdings in Cellebrite DI by 59.6% in the second quarter. Point72 Asia Singapore Pte. Ltd. now owns 2,724 shares of the company's stock valued at $33,000 after purchasing an additional 1,017 shares during the period. Advisors Asset Management Inc. increased its position in shares of Cellebrite DI by 130.5% in the third quarter. Advisors Asset Management Inc. now owns 3,077 shares of the company's stock valued at $52,000 after buying an additional 1,742 shares in the last quarter. Public Employees Retirement Association of Colorado acquired a new position in shares of Cellebrite DI during the 2nd quarter worth approximately $71,000. Finally, Pathway Financial Advisers LLC lifted its position in shares of Cellebrite DI by 1,583.8% during the 3rd quarter. Pathway Financial Advisers LLC now owns 4,378 shares of the company's stock valued at $74,000 after buying an additional 4,118 shares in the last quarter. Hedge funds and other institutional investors own 45.88% of the company's stock.

Cellebrite DI Stock Down 0.9 %

Shares of CLBT traded down $0.20 during mid-day trading on Friday, reaching $22.78. The company had a trading volume of 1,221,391 shares, compared to its average volume of 879,357. The stock has a market capitalization of $4.69 billion, a P/E ratio of -14.70, a PEG ratio of 3.18 and a beta of 1.46. Cellebrite DI has a 52-week low of $8.23 and a 52-week high of $23.50. The stock has a 50 day moving average of $20.76 and a two-hundred day moving average of $17.60.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.09 by $0.05. Cellebrite DI had a positive return on equity of 122.59% and a negative net margin of 82.28%. The business had revenue of $106.90 million for the quarter, compared to analyst estimates of $102.06 million. During the same quarter in the prior year, the firm posted $0.09 EPS. The business's quarterly revenue was up 27.0% compared to the same quarter last year. On average, sell-side analysts expect that Cellebrite DI will post 0.32 earnings per share for the current year.

Cellebrite DI Company Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.